Specialty Surgical Oncology Secures USD 2.8M Funding

By By Rediff Money Desk, Mumbai
Dec 08, 2025 16:16
Specialty Surgical Oncology (SSO) secures USD 2.8 million funding from Everhope Oncology platform. Expansion in Mumbai, Ahmedabad & Western India.
Mumbai, Dec 8 (PTI) Specialty Surgical Oncology Hospital (SSO) on Monday said it has secured USD 2.8 million (about Rs 25 crore) in funding from the Everhope Oncology platform, founded and backed by Narayana Health, W Health Ventures and 2070 Health.

"This partnership marks a defining moment for our team. It enables us to launch three new centres in Mumbai and invest deeply in clinical talent, advanced infrastructure and robust systems, so we can consistently deliver care at the highest possible standard," SSO founder Sanket Mehta said in a statement.

SSO will expand its presence across Western India, including Mumbai and Ahmedabad, and major cities in Maharashtra and Gujarat.
Source: PTI
Read More On:
specialty surgical oncologyeverhope oncology platformusd 2.8 million fundingnarayana healthmumbai
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

Rangsons Aerospace Wins Airbus Award

Rangsons Aerospace secures long-term award with Airbus to manufacture aviation tubes...

IIT Bombay & Groww Foundation: Deep-Tech...

IIT Bombay partners with Groww Foundation to boost deep-tech innovation & student...

CredFlow Gets NBFC Licence from RBI

CredFlow receives NBFC licence from RBI for SME lending. CashFloat operates under...

BSE Launches New Large-Cap Factor Indices

BSE Index Services launches four new large-cap factor indices: momentum, low...

Servier India Gets CDSCO Nod for Brain Cancer Drug

Servier India receives CDSCO approval for Vorasidenib (Voranigo), a brain cancer drug...

NTPC Green Energy Starts Bhuj Project Supply

NTPC Green Energy begins commercial power supply of 6.6 MW from its 100 MW hybrid...

Nifty to Hit 29,000 by 2026: Kotak Securities

Kotak Securities forecasts a 12% Nifty jump to 29,000 by end-2026, driven by strong...

Delius Pharma to Import Ceftriaxone API from China

Delius Pharma gets CDSCO approval to import Ceftriaxone Sodium API from China. Enhances...

Amul & Argentina Football Partnership Extended

Amul extends its partnership with the Argentina Football Association as Official...

FRAI Seeks Tech Platform for Kirana Stores

FRAI urges govt to create tech platform for kirana stores to compete with e-commerce....

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com